
|Articles|April 2, 2014
Cancer Centers Must Promote Culture in Support of Reimbursement for Clinical Trials
Author(s)David Evans, RN, MSN, MBA
At the ACCC 40th Annual National Meeting, David Evans, RN, MSN, MBA, discussed some of the top reimbursement issues that cancer centers face when it some to clinical trials.
Advertisement
At the ACCC 40th Annual National Meeting, David Evans, RN, MSN, MBA, discussed some of the top reimbursement issues that cancer centers face when it some to clinical trials. Evans says that an organization that is committed to offering clinical trials as treatment options should have, or needs to develop, a culture and infrastructure that promotes enrollments, supports patients in dealing with third-party payers, and challenges anyone who threatens to withhold reimbursement for the routine cost of cancer care.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Pembrolizumab Monotherapy Improves PFS in Frontline dMMR Endometrial Cancer
2
Agenus Discontinues Phase 3 BATTMAN Trial in Metastatic MSS Colorectal Cancer
3
How Do Updated NCCN Guidelines and ctDNA Data Reshape MIBC Treatment?
4
01 Real-World Outcomes of Radiation Omission After Breast-Conserving Surgery in Older Women With Stage I ER-Positive Breast Cancer: A SEER Analysis (2000–2022)
5
























































